These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Kethoxal bis(thiosemicarbazone). I. Effects against experimental tumors. Mihich E; Nichol CA Cancer Res; 1965 Oct; 25(9):1410-6. PubMed ID: 5217028 [No Abstract] [Full Text] [Related]
5. Bis-hydrazones of 1,4-diaminopiperazine as potential antimicrobial agents. Prescott B; Lones G; Caldes G Int Z Klin Pharmakol Ther Toxikol; 1968; 1(6):529-32. PubMed ID: 5718777 [No Abstract] [Full Text] [Related]
6. The carcinostatic activity of alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazones. II. 3-Hydroxypyridine-2-carboxaldehyde thiosemicarbazone. French FA; Blanz EJ Cancer Res; 1966 Aug; 26(8):1638-40. PubMed ID: 5923162 [No Abstract] [Full Text] [Related]
7. The effect of dietary mineral supplements of the rat on the antitumor activity of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone). Petering HG; Buskirk HH; Crim JA Cancer Res; 1967 Jun; 27(6):1115-21. PubMed ID: 6027202 [No Abstract] [Full Text] [Related]
8. Some antitumor agents derived from benzaldehyde nitrogen mustards. Florvall L Acta Pharm Suec; 1970 Apr; 7(2):87-104. PubMed ID: 5421623 [No Abstract] [Full Text] [Related]
9. Chemotherapy studies on experimental mouse tumors. X. French FA; Blanz EJ Cancer Chemother Rep 2; 1971 Apr; 2(1):199-235. PubMed ID: 5565536 [No Abstract] [Full Text] [Related]
10. New compounds: Oxazolidines and derived amino alcohols. Ager JH; May EL J Pharm Sci; 1969 Apr; 58(4):499-500. PubMed ID: 5787458 [No Abstract] [Full Text] [Related]
11. Effect of uracil mustard and several antitumor drugs on the primary antibody response in rats and mice. Buskirk HH; Crim JA; Petering HG; Merritt K; Johnson AG J Natl Cancer Inst; 1965 Jun; 34(6):747-58. PubMed ID: 4157755 [No Abstract] [Full Text] [Related]
12. The antitumor activity of Cu(II)KTS, the copper (II) chelate of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone). Crim JA; Petering HG Cancer Res; 1967 Jul; 27(7):1278-85. PubMed ID: 4952520 [No Abstract] [Full Text] [Related]
13. Potential antineoplastics. V. Synthesis of ethyl 2,3-dioxobutyrate 2-arylhydrazono-3-thiosemicarbazones. Garg HG; Sharma RA J Med Chem; 1970 Sep; 13(5):991-2. PubMed ID: 5458402 [No Abstract] [Full Text] [Related]
14. Sex-linked inhibition of tumors by pyruvaldehyde Bis(thiosemicarbazone). Cappuccino JG; Mountain IM; Tarnowski GS; Balis ME Cancer Res; 1967 Feb; 27(2):377-84. PubMed ID: 6071245 [No Abstract] [Full Text] [Related]
15. Evaluation of combination chemotherapy in vivo and in culture with l- -D-arabinofuranosylcytosine and 1-formylisoquinoline thiosemicarbazone. Grindey GB; Mihich E; Nichol CA Cancer Res; 1972 Mar; 32(3):522-6. PubMed ID: 5061306 [No Abstract] [Full Text] [Related]
16. Dibromodulcitol (NSC-104800)--clinical brochure. Carter SK Cancer Chemother Rep 3; 1968 Dec; 1(1):165-77. PubMed ID: 4989813 [No Abstract] [Full Text] [Related]
17. The carcinostatic activity of alpha-(N) heterocyclic carboxaldehyde thiosemicarbazones. I. Isoquinoline-1-carboxaldehyde thiosemicarbazone. French FA; Blanz EJ Cancer Res; 1965 Oct; 25(9):1454-8. PubMed ID: 5862990 [No Abstract] [Full Text] [Related]